Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   

COVID Reference, 5th edition, 486 pages

Free download

  Diseases of the Thyroid

  Free Subscription

Articles published in PLoS One

Retrieve available abstracts of 143 articles:
HTML format

Single Articles

    January 2020
  1. HASNAIN MJU, Shoaib M, Qadri S, Afzal B, et al
    Computational analysis of functional single nucleotide polymorphisms associated with SLC26A4 gene.
    PLoS One. 2020;15:e0225368.
    PubMed     Abstract available

  2. PARK VY, Han K, Kim HJ, Lee E, et al
    Radiomics signature for prediction of lateral lymph node metastasis in conventional papillary thyroid carcinoma.
    PLoS One. 2020;15:e0227315.
    PubMed     Abstract available

  3. PLAZINSKA MT, Sawicka-Gutaj N, Czarnywojtek A, Wolinski K, et al
    Radioiodine therapy and Graves' disease - Myths and reality.
    PLoS One. 2020;15:e0226495.
    PubMed     Abstract available

  4. SZLOSEK D, Robertson J, Quimby J, Mack R, et al
    A retrospective evaluation of the relationship between symmetric dimethylarginine, creatinine and body weight in hyperthyroid cats.
    PLoS One. 2020;15:e0227964.
    PubMed     Abstract available

  5. LEVY HC, Hulvey D, Adamson-Small L, Jn-Simon N, et al
    Improved cell-specificity of adeno-associated viral vectors for medullary thyroid carcinoma using calcitonin gene regulatory elements.
    PLoS One. 2020;15:e0228005.
    PubMed     Abstract available

  6. RICHARD MA, Lupo PJ, Morton LM, Yasui YA, et al
    Genetic variation in POT1 and risk of thyroid subsequent malignant neoplasm: A report from the Childhood Cancer Survivor Study.
    PLoS One. 2020;15:e0228887.
    PubMed     Abstract available

  7. TCHEANDJIEU C, Cordina-Duverger E, Mulot C, Baron-Dubourdieu D, et al
    Role of GSTM1 and GSTT1 genotypes in differentiated thyroid cancer and interaction with lifestyle factors: Results from case-control studies in France and New Caledonia.
    PLoS One. 2020;15:e0228187.
    PubMed     Abstract available

  8. YOON JH, Han K, Lee E, Lee J, et al
    Radiomics in predicting mutation status for thyroid cancer: A preliminary study using radiomics features for predicting BRAFV600E mutations in papillary thyroid carcinoma.
    PLoS One. 2020;15:e0228968.
    PubMed     Abstract available

  9. WALCZYK A, Kopczynski J, Gasior-Perczak D, Palyga I, et al
    Histopathology and immunohistochemistry as prognostic factors for poorly differentiated thyroid cancer in a series of Polish patients.
    PLoS One. 2020;15:e0229264.
    PubMed     Abstract available

  10. AL-SALAM S, Sharma C, Afandi B, Al Dahmani K, et al
    BRAF and KRAS mutations in papillary thyroid carcinoma in the United Arab Emirates.
    PLoS One. 2020;15:e0231341.
    PubMed     Abstract available

  11. BHALLA S, Kaur H, Kaur R, Sharma S, et al
    Expression based biomarkers and models to classify early and late-stage samples of Papillary Thyroid Carcinoma.
    PLoS One. 2020;15:e0231629.
    PubMed     Abstract available

  12. ZHANG J, Zhang X, Meng Y, Chen Y, et al
    Contrast-enhanced ultrasound for the differential diagnosis of thyroid nodules: An updated meta-analysis with comprehensive heterogeneity analysis.
    PLoS One. 2020;15:e0231775.
    PubMed     Abstract available

  13. ZHANG X, Liu L, Ma X, Hu W, et al
    Clinical significance of non-thyroidal illness syndrome on disease activity and dyslipidemia in patients with SLE.
    PLoS One. 2020;15:e0231622.
    PubMed     Abstract available

  14. HUANG CC, Lin YH, Kittipayak S, Hwua YS, et al
    Biokinetic model of radioiodine I-131 in nine thyroid cancer patients subjected to in-vivo gamma camera scanning: A simplified five-compartmental model.
    PLoS One. 2020;15:e0232480.
    PubMed     Abstract available

  15. DE SOUZA REIS R, Gatta G, de Camargo B
    Thyroid carcinoma in children, adolescents, and young adults in Brazil: A report from 11 population-based cancer registries.
    PLoS One. 2020;15:e0232416.
    PubMed     Abstract available

  16. CHENG Y, Huang Z, Liao Q, Yu X, et al
    Risk of second primary breast cancer among cancer survivors: Implications for prevention and screening practice.
    PLoS One. 2020;15:e0232800.
    PubMed     Abstract available

  17. SANDBLOM V, Spetz J, Shubbar E, Montelius M, et al
    Increased therapeutic effect on medullary thyroid cancer using a combination of radiation and tyrosine kinase inhibitors.
    PLoS One. 2020;15:e0233720.
    PubMed     Abstract available

  18. JUNG KY, Kim H, Choi HS, An JH, et al
    Clinical factors predicting the successful discontinuation of hormone replacement therapy in patients diagnosed with primary hypothyroidism.
    PLoS One. 2020;15:e0233596.
    PubMed     Abstract available

  19. SUBHI O, Schulten HJ, Bagatian N, Al-Dayini R, et al
    Genetic relationship between Hashimoto`s thyroiditis and papillary thyroid carcinoma with coexisting Hashimoto`s thyroiditis.
    PLoS One. 2020;15:e0234566.
    PubMed     Abstract available

  20. CASTILLO-GONZALEZ DA, Dorsey-Trevino EG, Gonzalez-Gonzalez JG, Garcia-Leal M, et al
    A deeper analysis in thyroid research: A meta-epidemiological study of the American Thyroid Association clinical guidelines.
    PLoS One. 2020;15:e0234297.
    PubMed     Abstract available

  21. CHOWDHURY R, Taneja S, Dhabhai N, Mazumder S, et al
    Burden of preconception morbidity in women of reproductive age from an urban setting in North India.
    PLoS One. 2020;15:e0234768.
    PubMed     Abstract available

  22. PARK KA, Eum SY, Oh H, Cho MH, et al
    Factors affecting online health community participation behavior in patients with thyroid cancer.
    PLoS One. 2020;15:e0235056.
    PubMed     Abstract available

  23. WANG X, Zhu J, Li Z, Wei T, et al
    The benefits of radioactive iodine ablation for patients with intermediate-risk papillary thyroid cancer.
    PLoS One. 2020;15:e0234843.
    PubMed     Abstract available

  24. KALISZEWSKI K, Diakowska D, Wojtczak B, Rudnicki J, et al
    Cancer screening activity results in overdiagnosis and overtreatment of papillary thyroid cancer: A 10-year experience at a single institution.
    PLoS One. 2020;15:e0236257.
    PubMed     Abstract available

  25. BYEON HJ, Kim JY, Ko J, Lee EJ, et al
    Protein tyrosine phosphatase 1B as a therapeutic target for Graves' orbitopathy in an in vitro model.
    PLoS One. 2020;15:e0237015.
    PubMed     Abstract available

  26. YOON JH, Jeon MJ, Kim M, Hong AR, et al
    Unusual metastases from differentiated thyroid cancers: A multicenter study in Korea.
    PLoS One. 2020;15:e0238207.
    PubMed     Abstract available

  27. PINTO N, Prokopec SD, Ghasemi F, Meens J, et al
    Flavopiridol causes cell cycle inhibition and demonstrates anti-cancer activity in anaplastic thyroid cancer models.
    PLoS One. 2020;15:e0239315.
    PubMed     Abstract available

  28. GANDY KC, Castillo HA, Ouellette L, Castillo J, et al
    The relationship between chronic health conditions and cognitive deficits in children, adolescents, and young adults with down syndrome: A systematic review.
    PLoS One. 2020;15:e0239040.
    PubMed     Abstract available

  29. XIONG J, Liu S, Hu K, Xiong Y, et al
    Study of reference intervals for free triiodothyronine, free thyroxine, and thyroid-stimulating hormone in an elderly Chinese Han population.
    PLoS One. 2020;15:e0239579.
    PubMed     Abstract available

    January 2019
  30. SCHMIDT P, Kempin R, Langner S, Beule A, et al
    Association of anthropometric markers with globe position: A population-based MRI study.
    PLoS One. 2019;14:e0211817.
    PubMed     Abstract available

  31. OWONIKOKO TK, Zhang G, Lallani SB, Chen Z, et al
    Evaluation of preclinical efficacy of everolimus and pasireotide in thyroid cancer cell lines and xenograft models.
    PLoS One. 2019;14:e0206309.
    PubMed     Abstract available

  32. LOTTATI M, Aucoin D, Bruyette DS
    Expected total thyroxine (TT4) concentrations and outlier values in 531,765 cats in the United States (2014-2015).
    PLoS One. 2019;14:e0213259.
    PubMed     Abstract available

  33. MUKTAR M, Roba KT, Mengistie B, Gebremichael B, et al
    Goiter and its associated factors among primary school children aged 6-12 years in Anchar district, Eastern Ethiopia.
    PLoS One. 2019;14:e0214927.
    PubMed     Abstract available

  34. AICHER KM, Cullen JM, Seiler GS, Lunn KF, et al
    Investigation of adrenal and thyroid gland dysfunction in dogs with ultrasonographic diagnosis of gallbladder mucocele formation.
    PLoS One. 2019;14:e0212638.
    PubMed     Abstract available

  35. AHI S, Amouzegar A, Gharibzadeh S, Delshad H, et al
    Trend of lipid and thyroid function tests in adults without overt thyroid diseases: A cohort from Tehran thyroid study.
    PLoS One. 2019;14:e0216389.
    PubMed     Abstract available

  36. LEI K, He X, Yu L, Ni C, et al
    Breast cancer prognosis is better in patients who develop subsequent metachronous thyroid cancer.
    PLoS One. 2019;14:e0215948.
    PubMed     Abstract available

  37. GIANNAKOU K, Evangelou E, Yiallouros P, Christophi CA, et al
    Risk factors for gestational diabetes: An umbrella review of meta-analyses of observational studies.
    PLoS One. 2019;14:e0215372.
    PubMed     Abstract available

  38. SHIN DH, Baek IC, Kim HJ, Choi EJ, et al
    HLA alleles, especially amino-acid signatures of HLA-DPB1, might contribute to the molecular pathogenesis of early-onset autoimmune thyroid disease.
    PLoS One. 2019;14:e0216941.
    PubMed     Abstract available

  39. YAMAUCHI I, Yasoda A, Matsumoto S, Sakamori Y, et al
    Incidence, features, and prognosis of immune-related adverse events involving the thyroid gland induced by nivolumab.
    PLoS One. 2019;14:e0216954.
    PubMed     Abstract available

  40. KANG SY, Bang JI, Kang KW, Lee HY, et al
    FDG PET/CT for the early prediction of RAI therapy response in patients with metastatic differentiated thyroid carcinoma.
    PLoS One. 2019;14:e0218416.
    PubMed     Abstract available

  41. LIU Z, Huang Y, Chen S, Hu D, et al
    Minimal extrathyroidal extension affects the prognosis of differentiated thyroid cancer: Is there a need for change in the AJCC classification system?
    PLoS One. 2019;14:e0218171.
    PubMed     Abstract available

  42. LEE HS, Lee JW, Park JH, Kim WS, et al
    Comprehensive analysis for diagnosis of preoperative non-invasive follicular thyroid neoplasm with papillary-like nuclear features.
    PLoS One. 2019;14:e0218046.
    PubMed     Abstract available

  43. OEVERHAUS M, Copei A, Mattheis S, Ringelstein A, et al
    Influence of orbital morphology on proptosis reduction and ocular motility after decompression surgery in patients with Graves' orbitopathy.
    PLoS One. 2019;14:e0218701.
    PubMed     Abstract available

  44. TOLA HH, Holakouie-Naieni K, Lejisa T, Mansournia MA, et al
    Is hypothyroidism rare in multidrug resistance tuberculosis patients on treatment? A systematic review and meta-analysis.
    PLoS One. 2019;14:e0218487.
    PubMed     Abstract available

  45. ZHU Y, Xu F, Shen J, Liu Y, et al
    Prevalence of thyroid dysfunction in older Chinese patients with type 2 diabetes-A multicenter cross-sectional observational study across China.
    PLoS One. 2019;14:e0216151.
    PubMed     Abstract available

  46. JANG SY, Chae MK, Lee JH, Lee EJ, et al
    MicroRNA-27 inhibits adipogenic differentiation in orbital fibroblasts from patients with Graves' orbitopathy.
    PLoS One. 2019;14:e0221077.
    PubMed     Abstract available

  47. WANG B, Zhu CR, Liu H, Wu J, et al
    The effectiveness of parathyroid gland autotransplantation in preserving parathyroid function during thyroid surgery for thyroid neoplasms: A meta-analysis.
    PLoS One. 2019;14:e0221173.
    PubMed     Abstract available

  48. HASSEN HY, Beyene M, Ali JH
    Dietary pattern and its association with iodine deficiency among school children in southwest Ethiopia; A cross-sectional study.
    PLoS One. 2019;14:e0221106.
    PubMed     Abstract available

  49. CORTES-CASTELL E, Juste M, Palazon-Bru A, Goicoechea M, et al
    Factors associated with moderate neonatal hyperthyrotropinemia.
    PLoS One. 2019;14:e0220040.
    PubMed     Abstract available

  50. DZIERLENGA MW, Allen BC, Ward PL, Clewell HJ 3rd, et al
    A model of functional thyroid disease status over the lifetime.
    PLoS One. 2019;14:e0219769.
    PubMed     Abstract available

  51. WU H, Zhang B, Cai G, Li J, et al
    American College of Radiology thyroid imaging report and data system combined with K-RAS mutation improves the management of cytologically indeterminate thyroid nodules.
    PLoS One. 2019;14:e0219383.
    PubMed     Abstract available

  52. CHENG W, Shen X, Xing M
    Decreased breast cancer-specific mortality risk in patients with a history of thyroid cancer.
    PLoS One. 2019;14:e0221093.
    PubMed     Abstract available

  53. NAKAMURA T, Ichii O, Sunden Y, Elewa YHA, et al
    Slc:Wistar/ST rats develop unilateral thyroid dysgenesis: A novel animal model of thyroid hemiagenesis.
    PLoS One. 2019;14:e0221939.
    PubMed     Abstract available

  54. TASHIRO R, Niizuma K, Khor SS, Tokunaga K, et al
    Identification of HLA-DRB1*04:10 allele as risk allele for Japanese moyamoya disease and its association with autoimmune thyroid disease: A case-control study.
    PLoS One. 2019;14:e0220858.
    PubMed     Abstract available

  55. TAN LO, Tan MG, Poon WB
    Lack of association between hypothyroxinemia of prematurity and transient thyroid abnormalities with adverse long term neurodevelopmental outcome in very low birth weight infants.
    PLoS One. 2019;14:e0222018.
    PubMed     Abstract available

  56. SANDBLOM V, Spetz J, Shubbar E, Montelius M, et al
    Gemcitabine potentiates the anti-tumour effect of radiation on medullary thyroid cancer.
    PLoS One. 2019;14:e0225260.
    PubMed     Abstract available

  57. GUERLAIN J, Perie S, Lefevre M, Perez J, et al
    Localization and characterization of thyroid microcalcifications: A histopathological study.
    PLoS One. 2019;14:e0224138.
    PubMed     Abstract available

  58. HAMMOND CL, Roztocil E, Phipps RP, Feldon SE, et al
    Proton pump inhibitors attenuate myofibroblast formation associated with thyroid eye disease through the aryl hydrocarbon receptor.
    PLoS One. 2019;14:e0222779.
    PubMed     Abstract available

  59. KELLY A, Barres B, Kwiatkowski F, Batisse-Lignier M, et al
    Age, thyroglobulin levels and ATA risk stratification predict 10-year survival rate of differentiated thyroid cancer patients.
    PLoS One. 2019;14:e0221298.
    PubMed     Abstract available

    January 2018
  60. WU H, Zhang B, Li J, Liu Q, et al
    Echogenic foci with comet-tail artifact in resected thyroid nodules: Not an absolute predictor of benign disease.
    PLoS One. 2018;13:e0191505.
    PubMed     Abstract available

  61. THVILUM M, Brandt F, Brix TH, Hegedus L, et al
    No evidence of a causal relationship between hypothyroidism and glaucoma: A Danish nationwide register-based cohort study.
    PLoS One. 2018;13:e0192311.
    PubMed     Abstract available

  62. SEO JW, Han K, Lee J, Kim EK, et al
    Application of metabolomics in prediction of lymph node metastasis in papillary thyroid carcinoma.
    PLoS One. 2018;13:e0193883.
    PubMed     Abstract available

  63. YEH CC, Su FH, Tzeng CR, Muo CH, et al
    Women with adenomyosis are at higher risks of endometrial and thyroid cancers: A population-based historical cohort study.
    PLoS One. 2018;13:e0194011.
    PubMed     Abstract available

  64. JUNG YS, Oh CM, Kim Y, Jung KW, et al
    Long-term survival of patients with thyroid cancer according to the methods of tumor detection: A nationwide cohort study in Korea.
    PLoS One. 2018;13:e0194743.
    PubMed     Abstract available

  65. MIZUGUCHI Y, Morimoto S, Kimura S, Takano N, et al
    Prediction of response to medical therapy by serum soluble (pro)renin receptor levels in Graves' disease.
    PLoS One. 2018;13:e0195464.
    PubMed     Abstract available

  66. MASSOLT ET, Chaker L, Visser TJ, Gillis AJM, et al
    Serum microRNA profiles in athyroid patients on and off levothyroxine therapy.
    PLoS One. 2018;13:e0194259.
    PubMed     Abstract available

  67. PARK B, Min C, Choi HG
    Neck dissection does not increases the risk of stroke in thyroid cancer: A national cohort study.
    PLoS One. 2018;13:e0195074.
    PubMed     Abstract available

  68. GONG Y, Yang J, Wu W, Liu F, et al
    Preserved SCN4B expression is an independent indicator of favorable recurrence-free survival in classical papillary thyroid cancer.
    PLoS One. 2018;13:e0197007.
    PubMed     Abstract available

  69. SCHNEIDER C, Feller M, Bauer DC, Collet TH, et al
    Initial evaluation of thyroid dysfunction - Are simultaneous TSH and fT4 tests necessary?
    PLoS One. 2018;13:e0196631.
    PubMed     Abstract available

  70. KIM MJ, Moon S, Oh BC, Jung D, et al
    Association between perfluoroalkyl substances exposure and thyroid function in adults: A meta-analysis.
    PLoS One. 2018;13:e0197244.
    PubMed     Abstract available

  71. GALDIERO MR, Varricchi G, Loffredo S, Bellevicine C, et al
    Potential involvement of neutrophils in human thyroid cancer.
    PLoS One. 2018;13:e0199740.
    PubMed     Abstract available

  72. SU H, Rei N, Zhang L, Cheng J, et al
    Meta-analyses of IL1A polymorphisms and the risk of several autoimmune diseases published in databases.
    PLoS One. 2018;13:e0198693.
    PubMed     Abstract available

  73. WANG Q, Guo Y, Zhang J, Shi L, et al
    Utility of high b-value (2000 sec/mm2) DWI with RESOLVE in differentiating papillary thyroid carcinomas and papillary thyroid microcarcinomas from benign thyroid nodules.
    PLoS One. 2018;13:e0200270.
    PubMed     Abstract available

  74. LABARGE B, Walter V, Lengerich EJ, Crist H, et al
    Evidence of a positive association between malpractice climate and thyroid cancer incidence in the United States.
    PLoS One. 2018;13:e0199862.
    PubMed     Abstract available

  75. WANG X, Huang S, Li X, Jiang D, et al
    A potential biomarker hsa-miR-200a-5p distinguishing between benign thyroid tumors with papillary hyperplasia and papillary thyroid carcinoma.
    PLoS One. 2018;13:e0200290.
    PubMed     Abstract available

  76. SHI Y, Su C, Hu H, Yan H, et al
    Serum MMP-2 as a potential predictive marker for papillary thyroid carcinoma.
    PLoS One. 2018;13:e0198896.
    PubMed     Abstract available

  77. LIN Z, Yang Z, He B, Wang D, et al
    Pattern of radiation-induced thyroid gland changes in nasopharyngeal carcinoma patients in 48 months after radiotherapy.
    PLoS One. 2018;13:e0200310.
    PubMed     Abstract available

  78. SHIMAMURA M, Shibusawa N, Kurashige T, Mussazhanova Z, et al
    Mouse models of sporadic thyroid cancer derived from BRAFV600E alone or in combination with PTEN haploinsufficiency under physiologic TSH levels.
    PLoS One. 2018;13:e0201365.
    PubMed     Abstract available

  79. SEONG CY, Chai YJ, Lee SM, Kim SJ, et al
    Significance of distance between tumor and thyroid capsule as an indicator for central lymph node metastasis in clinically node negative papillary thyroid carcinoma patients.
    PLoS One. 2018;13:e0200166.
    PubMed     Abstract available

  80. KIM RB, Kim M, Cho YY, Kim SK, et al
    Thyroid function tests in patients at the emergency department compared to a prior healthy setting.
    PLoS One. 2018;13:e0202422.
    PubMed     Abstract available

  81. LEE CH, Jung JH, Son SH, Hong CM, et al
    Risk factors for radioactive iodine-avid metastatic lymph nodes on post I-131 ablation SPECT/CT in low- or intermediate-risk groups of papillary thyroid cancer.
    PLoS One. 2018;13:e0202644.
    PubMed     Abstract available

  82. HONG JW, Noh JH, Kim DJ
    Association between subclinical thyroid dysfunction and depressive symptoms in the Korean adult population: The 2014 Korea National Health and Nutrition Examination Survey.
    PLoS One. 2018;13:e0202258.
    PubMed     Abstract available

  83. BASHIR K, Sarwar R, Saeed S, Mahjabeen I, et al
    Interaction among susceptibility genotypes of PARP1 SNPs in thyroid carcinoma.
    PLoS One. 2018;13:e0199007.
    PubMed     Abstract available

  84. KIM DS, Kim DW, Heo YJ, Baek JW, et al
    Utility of including BRAF mutation analysis with ultrasonographic and cytological diagnoses in ultrasonography-guided fine-needle aspiration of thyroid nodules.
    PLoS One. 2018;13:e0202687.
    PubMed     Abstract available

  85. MAKRETSKAYA N, Bezlepkina O, Kolodkina A, Kiyaev A, et al
    High frequency of mutations in 'dyshormonogenesis genes' in severe congenital hypothyroidism.
    PLoS One. 2018;13:e0204323.
    PubMed     Abstract available

  86. KYRIAKIDOU G, Friedrich-Rust M, Bon D, Sircar I, et al
    Comparison of strain elastography, point shear wave elastography using acoustic radiation force impulse imaging and 2D-shear wave elastography for the differentiation of thyroid nodules.
    PLoS One. 2018;13:e0204095.
    PubMed     Abstract available

  87. GASIOR-PERCZAK D, Palyga I, Szymonek M, Kowalik A, et al
    The impact of BMI on clinical progress, response to treatment, and disease course in patients with differentiated thyroid cancer.
    PLoS One. 2018;13:e0204668.
    PubMed     Abstract available

  88. NAGATA T, Nakajima S, Fujiya A, Sobajima H, et al
    Prevalence of hypothyroidism in patients with hyponatremia: A retrospective cross-sectional study.
    PLoS One. 2018;13:e0205687.
    PubMed     Abstract available

  89. BAEK HJ, Kim DW, Lee YJ, Choo HJ, et al
    Diagnostic accuracy of computed tomography for differentiating diffuse thyroid disease from normal thyroid parenchyma: A multicenter study.
    PLoS One. 2018;13:e0205507.
    PubMed     Abstract available

  90. CHEN L, Wang J, Jiang P, Ren F, et al
    Alteration of the colostrum whey proteome in mothers with gestational hypothyroidism.
    PLoS One. 2018;13:e0205987.
    PubMed     Abstract available

  91. NAM JY, Choi Y, Jung MK, Shin J, et al
    The effect of neonatal hypothyroidism and low family income on intellectual disability: A population-based cohort study.
    PLoS One. 2018;13:e0205955.
    PubMed     Abstract available

    January 2017
  92. JEONG H, Baek SY, Kim SW, Eun YH, et al
    Comorbidities of rheumatoid arthritis: Results from the Korean National Health and Nutrition Examination Survey.
    PLoS One. 2017;12:e0176260.
    PubMed     Abstract available

  93. CAMPO C, Kohler A, Figlioli G, Elisei R, et al
    Inherited variants in genes somatically mutated in thyroid cancer.
    PLoS One. 2017;12:e0174995.
    PubMed     Abstract available

  94. KIM SY, Lee E, Nam SJ, Kim EK, et al
    Ultrasound texture analysis: Association with lymph node metastasis of papillary thyroid microcarcinoma.
    PLoS One. 2017;12:e0176103.
    PubMed     Abstract available

  95. ZHANG Y, Wang H, Pan X, Teng W, et al
    Patients with subclinical hypothyroidism before 20 weeks of pregnancy have a higher risk of miscarriage: A systematic review and meta-analysis.
    PLoS One. 2017;12:e0175708.
    PubMed     Abstract available

  96. AASS C, Norheim I, Eriksen EF, Bornick EC, et al
    Establishment of a tear protein biomarker panel differentiating between Graves' disease with or without orbitopathy.
    PLoS One. 2017;12:e0175274.
    PubMed     Abstract available

  97. CATALANI S, Palma F, Battistelli S, Benedetti S, et al
    Oxidative stress and apoptosis induction in human thyroid carcinoma cells exposed to the essential oil from Pistacia lentiscus aerial parts.
    PLoS One. 2017;12:e0172138.
    PubMed     Abstract available

  98. AMOUZEGAR A, Gharibzadeh S, Kazemian E, Mehran L, et al
    The Prevalence, Incidence and Natural Course of Positive Antithyroperoxidase Antibodies in a Population-Based Study: Tehran Thyroid Study.
    PLoS One. 2017;12:e0169283.
    PubMed     Abstract available

  99. KATAGIRI R, Yuan X, Kobayashi S, Sasaki S, et al
    Effect of excess iodine intake on thyroid diseases in different populations: A systematic review and meta-analyses including observational studies.
    PLoS One. 2017;12:e0173722.
    PubMed     Abstract available

  100. JOHNS LE, Ferguson KK, McElrath TF, Mukherjee B, et al
    Longitudinal Profiles of Thyroid Hormone Parameters in Pregnancy and Associations with Preterm Birth.
    PLoS One. 2017;12:e0169542.
    PubMed     Abstract available

  101. KIM Y, Kim MH, Jeon S, Kim J, et al
    Prognostic implication of histological features associated with EHD2 expression in papillary thyroid carcinoma.
    PLoS One. 2017;12:e0174737.
    PubMed     Abstract available

  102. XIU L, Zhong G, Ma X
    Urinary iodine concentration (UIC) could be a promising biomarker for predicting goiter among school-age children: A systematic review and meta-analysis.
    PLoS One. 2017;12:e0174095.
    PubMed     Abstract available

  103. KIM HI, Kim TH, Kim H, Kim YN, et al
    Effect of Rifampin on Thyroid Function Test in Patients on Levothyroxine Medication.
    PLoS One. 2017;12:e0169775.
    PubMed     Abstract available

  104. XIA N, Ye X, Hu X, Song S, et al
    Simultaneous induction of Graves' hyperthyroidism and Graves' ophthalmopathy by TSHR genetic immunization in BALB/c mice.
    PLoS One. 2017;12:e0174260.
    PubMed     Abstract available

  105. LIN JD, Lin SF, Chen ST, Hsueh C, et al
    Long-term follow-up of papillary and follicular thyroid carcinomas with bone metastasis.
    PLoS One. 2017;12:e0173354.
    PubMed     Abstract available

  106. LIN SF, Lin JD, Hsueh C, Chou TC, et al
    A cyclin-dependent kinase inhibitor, dinaciclib in preclinical treatment models of thyroid cancer.
    PLoS One. 2017;12:e0172315.
    PubMed     Abstract available

  107. ZHANG M, Qin Y, Zuo B, Gong W, et al
    Overexpression of NOTCH-regulated Ankyrin Repeat Protein is associated with papillary thyroid carcinoma progression.
    PLoS One. 2017;12:e0167782.
    PubMed     Abstract available

  108. LI Q, Ye H, Ding Y, Chen G, et al
    Clinical characteristics of moderate-to-severe thyroid associated ophthalmopathy in 354 Chinese cases.
    PLoS One. 2017;12:e0176064.
    PubMed     Abstract available

  109. FERNSTROM J, Westrin A, Grudet C, Traskman-Bendz L, et al
    Six autoantibodies associated with autoimmune encephalitis are not detectable in the cerebrospinal fluid of suicide attempters.
    PLoS One. 2017;12:e0176358.
    PubMed     Abstract available

  110. FRANCESCHI S, Lessi F, Panebianco F, Tantillo E, et al
    Loss of c-KIT expression in thyroid cancer cells.
    PLoS One. 2017;12:e0173913.
    PubMed     Abstract available

  111. PENG N, Shi L, Zhang Q, Hu Y, et al
    Microarray profiling of circular RNAs in human papillary thyroid carcinoma.
    PLoS One. 2017;12:e0170287.
    PubMed     Abstract available

  112. WANG C, Zhang X, Li H, Li X, et al
    Quantitative thyroglobulin response to radioactive iodine treatment in predicting radioactive iodine-refractory thyroid cancer with pulmonary metastasis.
    PLoS One. 2017;12:e0179664.
    PubMed     Abstract available

  113. YUN JS, Bae JM, Kim KJ, Jung YS, et al
    Increased risk of thyroid diseases in patients with systemic lupus erythematosus: A nationwide population-based Study in Korea.
    PLoS One. 2017;12:e0179088.
    PubMed     Abstract available

  114. KRONBORG TM, Hansen JF, Rasmussen AK, Vorkamp K, et al
    The flame retardant DE-71 (a mixture of polybrominated diphenyl ethers) inhibits human differentiated thyroid cell function in vitro.
    PLoS One. 2017;12:e0179858.
    PubMed     Abstract available

  115. KOWALIK A, Kowalska A, Walczyk A, Chodurska R, et al
    Evaluation of molecular diagnostic approaches for the detection of BRAF p.V600E mutations in papillary thyroid cancer: Clinical implications.
    PLoS One. 2017;12:e0179691.
    PubMed     Abstract available

  116. PARK YM, Lee SM, Kim DW, Shin SC, et al
    Predictive factors of right paraesophageal lymph node metastasis in papillary thyroid carcinoma: Single center experience and meta-analysis.
    PLoS One. 2017;12:e0177956.
    PubMed     Abstract available

  117. LUBITZ C, Ali A, Zhan T, Heberle C, et al
    The thyroid cancer policy model: A mathematical simulation model of papillary thyroid carcinoma in The U.S. population.
    PLoS One. 2017;12:e0177068.
    PubMed     Abstract available

  118. CHOW LQ, Santana-Davila R, Pantel A, Roth M, et al
    A phase I study of pazopanib in combination with escalating doses of 131I in patients with well-differentiated thyroid carcinoma borderline refractory to radioiodine.
    PLoS One. 2017;12:e0178325.
    PubMed     Abstract available

  119. JEGERLEHNER S, Bulliard JL, Aujesky D, Rodondi N, et al
    Overdiagnosis and overtreatment of thyroid cancer: A population-based temporal trend study.
    PLoS One. 2017;12:e0179387.
    PubMed     Abstract available

  120. YANG D, Wang C, Luo Y, Li X, et al
    Activated E2F activity induces cell death in papillary thyroid carcinoma K1 cells with enhanced Wnt signaling.
    PLoS One. 2017;12:e0178908.
    PubMed     Abstract available

  121. KANG YY, Liu Y, Wang ML, Guo M, et al
    Construction and analyses of the microRNA-target gene differential regulatory network in thyroid carcinoma.
    PLoS One. 2017;12:e0178331.
    PubMed     Abstract available

  122. KIM H, Kim TH, Kim HI, Park SY, et al
    Subclinical thyroid dysfunction and risk of carotid atherosclerosis.
    PLoS One. 2017;12:e0182090.
    PubMed     Abstract available

  123. WANG Y, Brule E, Silander T, Bak B, et al
    The short mRNA isoform of the immunoglobulin superfamily, member 1 gene encodes an intracellular glycoprotein.
    PLoS One. 2017;12:e0180731.
    PubMed     Abstract available

  124. BUFFET C, Hecale-Perlemoine K, Bricaire L, Dumont F, et al
    DUSP5 and DUSP6, two ERK specific phosphatases, are markers of a higher MAPK signaling activation in BRAF mutated thyroid cancers.
    PLoS One. 2017;12:e0184861.
    PubMed     Abstract available

  125. KHATAMI F, Larijani B, Heshmat R, Keshtkar A, et al
    Meta-analysis of promoter methylation in eight tumor-suppressor genes and its association with the risk of thyroid cancer.
    PLoS One. 2017;12:e0184892.
    PubMed     Abstract available

  126. MEI D, Lv B, Chen B, Xiao S, et al
    All-trans retinoic acid suppresses malignant characteristics of CD133-positive thyroid cancer stem cells and induces apoptosis.
    PLoS One. 2017;12:e0182835.
    PubMed     Abstract available

  127. WANG L, Cao F, Wang S, Sun M, et al
    Using k-dependence causal forest to mine the most significant dependency relationships among clinical variables for thyroid disease diagnosis.
    PLoS One. 2017;12:e0182070.
    PubMed     Abstract available

  128. GHOLAMPOUR DEHAKI M, Amouzegar A, Delshad H, Mehrabi Y, et al
    Thyroid dysfunction in patients with impaired glucose metabolism: 11 year follow up from the Tehran Thyroid Study.
    PLoS One. 2017;12:e0184808.
    PubMed     Abstract available

  129. LIN JD, Yang SF, Wang YH, Fang WF, et al
    Associations of melatonin receptor gene polymorphisms with Graves' disease.
    PLoS One. 2017;12:e0185529.
    PubMed     Abstract available

  130. WANG S, Liu Y, Zheng G
    Hypothyroidism as a risk factor for open angle glaucoma: A systematic review and meta-analysis.
    PLoS One. 2017;12:e0186634.
    PubMed     Abstract available

  131. NAM SJ, Kwak JY, Moon HJ, Yoon JH, et al
    Large (>/=3cm) thyroid nodules with benign cytology: Can Thyroid Imaging Reporting and Data System (TIRADS) help predict false-negative cytology?
    PLoS One. 2017;12:e0186242.
    PubMed     Abstract available

  132. HOERMANN R, Midgley JEM, Larisch R, Dietrich JWC, et al
    Advances in applied homeostatic modelling of the relationship between thyrotropin and free thyroxine.
    PLoS One. 2017;12:e0187232.
    PubMed     Abstract available

  133. HE C, Ma J, Jiang Y, Su X, et al
    Associations between RET tagSNPs and their haplotypes and susceptibility, clinical severity, and thyroid function in patients with differentiated thyroid cancer.
    PLoS One. 2017;12:e0187968.
    PubMed     Abstract available

  134. LOZANO-VELASCO E, Wangensteen R, Quesada A, Garcia-Padilla C, et al
    Hyperthyroidism, but not hypertension, impairs PITX2 expression leading to Wnt-microRNA-ion channel remodeling.
    PLoS One. 2017;12:e0188473.
    PubMed     Abstract available

  135. GOLBERT L, de Cristo AP, Faccin CS, Farenzena M, et al
    Serum TSH levels as a predictor of malignancy in thyroid nodules: A prospective study.
    PLoS One. 2017;12:e0188123.
    PubMed     Abstract available

  136. PANG T, Huang L, Deng Y, Wang T, et al
    Logistic regression analysis of conventional ultrasonography, strain elastosonography, and contrast-enhanced ultrasound characteristics for the differentiation of benign and malignant thyroid nodules.
    PLoS One. 2017;12:e0188987.
    PubMed     Abstract available

    January 2016
  137. GAO X, Liu M, Qu A, Chen Z, et al
    Native Magnetic Resonance T1-Mapping Identifies Diffuse Myocardial Injury in Hypothyroidism.
    PLoS One. 2016;11:e0151266.
    PubMed     Abstract available

  138. TING WH, Chien MN, Lo FS, Wang CH, et al
    Association of Cytotoxic T-Lymphocyte-Associated Protein 4 (CTLA4) Gene Polymorphisms with Autoimmune Thyroid Disease in Children and Adults: Case-Control Study.
    PLoS One. 2016;11:e0154394.
    PubMed     Abstract available

  139. AHMED RH, Huri HZ, Al-Hamodi Z, Salem SD, et al
    Association of DPP4 Gene Polymorphisms with Type 2 Diabetes Mellitus in Malaysian Subjects.
    PLoS One. 2016;11:e0154369.
    PubMed     Abstract available

  140. CHOI J, Kim JW, Keum YS, Lee IJ, et al
    The Largest Known Survival Analysis of Patients with Brain Metastasis from Thyroid Cancer Based on Prognostic Groups.
    PLoS One. 2016;11:e0154739.
    PubMed     Abstract available

  141. YU J, Tian AJ, Yuan X, Cheng XX, et al
    Subclinical Hypothyroidism after 131I-Treatment of Graves' Disease: A Risk Factor for Depression?
    PLoS One. 2016;11:e0154846.
    PubMed     Abstract available

  142. ZHAO Z, Zou J, Zhao L, Cheng Y, et al
    Celiac Disease Autoimmunity in Patients with Autoimmune Diabetes and Thyroid Disease among Chinese Population.
    PLoS One. 2016;11:e0157510.
    PubMed     Abstract available

  143. CIAPPUCCINI R, Aide N, Blanchard D, Rame JP, et al
    Incremental Value of a Dedicated Head and Neck Acquisition during 18F-FDG PET/CT in Patients with Differentiated Thyroid Cancer.
    PLoS One. 2016;11:e0162482.
    PubMed     Abstract available

Thank you for your interest in scientific medicine.

AMEDEO Diseases of the Thyroid is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.